Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01132014
Title Autologous OC-DC Vaccine in Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

peritoneal carcinoma

fallopian tube cancer

ovarian cancer

Therapies

Bevacizumab

Dacarbazine

Age Groups: adult
Covered Countries USA


No variant requirements are available.